Rossari Bio wins Sebi approval for Rp7bn IPO
India's market regulator has given Rossari Biotech the nod for an IPO that is expected to raise about Rp7bn ($98m).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts